← back to search

Laura D. Gauthier

Broad Institute ·
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Genomics and Rare Diseases, Genomic variations and chromosomal abnormalities, Genomics and Phylogenetic Studies, and Genetic Associations and Epidemiology.
h-index
34
citations
33,462
works
72
NIH funding
primary concept
Biology
email

Recent publications

Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database
Nature Communications 2025cited by 10position: middledoi
Genomic data in the All of Us Research Program
Nature 2024cited by 711position: middledoi
Author Correction: A genomic mutational constraint map using variation in 76,156 human genomes
Nature 2024cited by 175position: middledoi
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes
Nature Neuroscience 2024cited by 48position: middledoi
A genomic mutational constraint map using variation in 76,156 human genomes
Nature 2023cited by 1,273position: middledoi
Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death
Nature Medicine 2023cited by 62position: middledoi
Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomalies
The American Journal of Human Genetics 2023cited by 54position: middledoi
Inferring compound heterozygosity from large-scale exome sequencing data
Nature Genetics 2023cited by 34position: middledoi
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism
Nature Genetics 2022cited by 602position: middledoi
Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans
Nature 2021cited by 61position: middledoi
Rare coding variation illuminates the allelic architecture, risk genes, cellular expression patterns, and phenotypic context of autism
medRxiv 2021cited by 35position: middledoi
Author Correction: A structural variation reference for medical and population genetics
Nature 2021cited by 17position: middledoi
The mutational constraint spectrum quantified from variation in 141,456 humans
Nature 2020cited by 10,012position: middledoi
A structural variation reference for medical and population genetics
Nature 2020cited by 1,155position: middledoi
Transcript expression-aware annotation improves rare variant interpretation
Nature 2020cited by 201position: middledoi
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals
Nature Communications 2020cited by 191position: middledoi
Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes
Nature Communications 2020cited by 143position: middledoi
The effect of LRRK2 loss-of-function variants in humans
Nature Medicine 2020cited by 109position: middledoi
Landscape of X chromosome inactivation across human tissues
Nature 2017cited by 1,196position: middledoi
Analysis of protein-coding genetic variation in 60,706 humans
Nature 2016cited by 10,290position: middledoi
Analysis of protein-coding genetic variation in 60,706 humans
bioRxiv (Cold Spring Harbor Laboratory) 2015cited by 143position: middledoi
Metabolite Profiling and Classification of DNA-Authenticated Licorice Botanicals
Journal of Natural Products 2015cited by 50position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Konrad J. Karczewski · Broad Institute1 papers (2017–2017) · 1 papers (2017–2017)Manuel A. Rivas · Centre for Human Genetics1 papers (2017–2017)Daniel G. MacArthur · Garvan Institute of Medical Research1 papers (2017–2017)Aviv Regev · Moscow Institute of Thermal Technology1 papers (2017–2017)Charlotte Simmler · University of Illinois Chicago1 papers (2015–2015)Shao‐Nong Chen · University of Illinois Chicago1 papers (2015–2015)Taru Tukiainen · Massachusetts Institute of Technology1 papers (2017–2017)Beryl B. Cummings · Broad Institute1 papers (2017–2017)James B. McAlpine · University of Illinois Chicago1 papers (2015–2015)Andrea Byrnes · Novartis (Switzerland)1 papers (2017–2017)David C. Lankin · University of Illinois Chicago1 papers (2015–2015)Stephane E. Castel · University of Washington1 papers (2017–2017)Alexandra–Chloé Villani · Broad Institute1 papers (2017–2017)Nir Hacohen · Broad Institute1 papers (2017–2017) · 1 papers (2017–2017)Kristin Ardlie · Broad Institute1 papers (2017–2017)Rahul Satija · Genomics (United Kingdom)1 papers (2017–2017)Jamie L. Marshall · Solidus Biosciences (United States)1 papers (2017–2017) · 1 papers (2017–2017)